Hereditary Hemorrhagic Telangiectasia Foundation
patient advocacy organization for individuals suffering from a rare disease
Based in MD
🤖
AI Overview
With $330K in lobbying spend across 33 quarterly filings, Hereditary Hemorrhagic Telangiectasia Foundation is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$330K
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $40K |
| 2019 | $40K |
| 2020 | $50K |
| 2021 | $40K |
| 2022 | $40K |
| 2023 | $40K |
| 2024 | $40K |
| 2025 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, Health Issues, Budget/Appropriations, MED
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.